Bottle, A. ., Adamson, A. ., Zhang, X. ., Hayhoe, B. ., & J, Q. . (2024). What happens between first symptoms and first acute exacerbation of COPD - observational study of routine data and patient survey. Health Soc Care Deliv Res, 12, 1–80. http://doi.org/10.3310/cgtr6370
Disease Progression
Elhussein, L. ., Robinson, D. E., Delmestri, A. ., Clegg, A. ., Prieto-Alhambra, D. ., Silman, A. ., & . Y. Strauss, V. . (2024). Longitudinal trajectories of frailty are associated with short-term mortality in older people: a joint latent class models analysis using 2 UK primary care databases. J Clin Epidemiol, 173, 111442. http://doi.org/10.1016/j.jclinepi.2024.111442
Graul, E. L., Nordon, C. ., Rhodes, K. ., Menon, S. ., Ammouri, A. ., Kallis, C. ., … Quint, J. K. (2024). Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study. BMC Pulm Med, 24, 221. http://doi.org/10.1186/s12890-024-03035-4
Whittaker, H. R., Torkpour, A. ., & Quint, J. . (2024). Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data. Respir Res, 25, 43. http://doi.org/10.1186/s12931-024-02672-x
Whittaker, H. ., Rothnie, K. J., & Quint, J. K. (2023). Exploring the impact of varying definitions of exacerbations of chronic obstructive pulmonary disease in routinely collected electronic medical records. PLoS One, 18, e0292876. http://doi.org/10.1371/journal.pone.0292876
Rothnie, K. J., Numbere, B. ., Gelwicks, S. ., Lu, Y. ., Sharma, R. ., Compton, C. ., … Quint, J. K. (2023). Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. Int J Chron Obstruct Pulmon Dis, 18, 2673–2685. http://doi.org/10.2147/copd.s413947
Chen, S. ., Miravitlles, M. ., Rhee, C. K., Pavord, I. D., Jones, R. ., Carter, V. ., … Price, D. B. (2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187–2200. http://doi.org/10.2147/copd.s378649
Whittaker, H. ., Van Ganse, E. ., Dalon, F. ., Nolin, M. ., Marrant-Micallef, C. ., Pison, C. ., … Belhassen, M. . (2022). Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. BMJ Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2021-001150
Aoki, Y. ., Cabrera, C. S., Ouwens, M. ., Bamberg, K. ., Nyström, J. ., Raz, I. ., … Rekić, D. . (2022). Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data. PLoS One, 17, e0269970. http://doi.org/10.1371/journal.pone.0269970
Sansbury, L. B., Rothnie, K. J., Bains, C. ., Compton, C. ., Anley, G. ., & Ismaila, A. S. (2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. Int J Chron Obstruct Pulmon Dis, 16, 2591–2604. http://doi.org/10.2147/copd.s318969